Torres-Lobatón A, Barra-Martínez R, Jiménez-Arroyo EP, Portillo-Reyes J, Suárez-Juárez CA, Morgan-Ortiz F

Language: Spanish
References: 15
Page: 569-574
PDF size: 207.00 Kb.

ABSTRACT

Objective: To describe the increase shown in the frequency of endometrial cancer in a tertiary hospital in the last decades and its association with overweight and obesity.
Materials and Methods: Retrospective, comparative and observational study based on information from the files of patients with a diagnosis of endometrial cancer attended at the Oncology Service of the General Hospital of Mexico (2000-2017). Data were compared with a previous study from 1966-1993.
Results: From 2000 to 2017, 785 patients were registered and in the global period of 44 years, 1045 patients were included in the study. In the 27-year period, 260 patients were registered, and in the 17-year period, 785 patients were registered; that is, a 200% increase in the frequency of this disease.
Conclusions: In this series the percentages of overweight and obesity rose from 46 to 72.5%. Endometrial cancer in women under 48 years of age increased from 19 to 28%. 30.5% of patients in early stages of endometrial cancer had risk factors for tumor recurrence and 42% of the overall series had advanced neoplasms, which is shown to affect their prognosis.

REFERENCES

1. Santaballa A, et al. SEOM clinical guidelines for endometrial cancer (2017). Clin and Translat Oncol 2018; 20: 29-37. doi:10.1007/s12094-017-1809-9.

2. Smith RA, et al. Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening. Cancer J Clinician 2018; 68 (4). h ttps://doi.org/10.3322/caac.21446

3. Rtveladze K, et al. Obesity prevalence in Mexico: impact on health and economic burden. Public Health Nutrition 2014; 17 (1): 233-39. https://doi.org/10.1017/ S1368980013000086

4. Fernández CSB, et al. Perfil epidemiológico de los tumores malignos en México. Dirección General de Epidemiología. (SINAIS/SINAVE/DGE/Salud). Ciudad de México: Secretaría de Salud, 2011; 46-122.

5. Onstad AM, et al. Addressing de role of obesity. Endometrial cancer risk, prevention, and treatment. J Clin Oncol. 2016; 34: 4225-30. doi:10.1200/JCO.2016.69.4638.

6. Nevadunsky SN, et al. Obesity and age at diagnosis of endometrial cancer. Obstet Gynecol. 2014; 124: 300-6. Doi:10.1097/AOG.0000000000000381.

7. Campos NI, et al. Epidemiología de la obesidad y sus principales comorbilidades en México. En: La Obesidad en México. Estado de la política pública y recomendaciones para su prevención y control.

8. Editores: Juan Ángel Rivera Dommarco, Maranta Colchero y col. México: Instituto Nacional de Salud Pública, 2018; 31-38.

9. Encuesta Nacional de Salud y Nutrición 2018. Presentación de resultados. ensanut.insp.mx>informes>ensanut_2018_ presentacion_resultados. 2019; 41.

10. Torres LA, et al. Cáncer ginecológico, 1983-1984. Frecuencia relativa y resultados del tratamiento. Unidad de Oncología. Hospital General de México. Rev Med Hosp Gen (Mex) 1987; 50: 169-77.

11. Torres LA, et al. Cáncer ginecológico: evolución de su frecuencia relativa en una Institución de alta especialidad. Gac Mex Oncol (GAMO) 2014; 13: 222-28.

12. Uterine Neoplasms. NCCN clinical Practice Guidelines in Oncology (NCCN Guidelines) 2019. Endo 4-10.

13. Torres LA, et al. Cáncer del endometrio en el Hospital General de México: 27 años de experiencia. Rev Inst Nal Cancerol (Mex) 1998; 44: 124-33.

14. Islami F, et al. Gobal Cancer In Women: Cancer Control Priorities. Cancer Epidemiol Biomarkers Prev. 2017; 26: 458-70. doi:10.1158/1055-9965.EPI-16-0871.

15. Sanz-Chávez LNT, et al. Sobrepeso, obesidad, diabetes e hipertensión en cáncer de endometrio. Rev Med Inst Mex Seguro Soc. 2013; 51: 326-29.